PI3K-mTOR pathway identified as a potential therapeutic target in biliary tract cancer using a newly established

Yasunari Sakamoto1, Seri Yamagishi2, Yoshinori Tanizawa3

  • 1Department of Hepatobiliary and Pancreatic Oncology, Tokyo, National Cancer Center Hospital.

Insights

Novel therapies for biliary tract carcinoma (BTC) are needed. A PI3K/mTOR dual inhibitor demonstrated significant activity against 13 of 17 BTC cell lines, suggesting its potential for drug development.

Area of Science:

  • Oncology
  • Drug Discovery
  • Gastroenterology

Background:

  • Biliary tract carcinoma (BTC) is a highly malignant cancer with limited treatment options.
  • There is a critical need for novel therapeutic strategies and accessible resources for drug evaluation in BTC.
  • Existing BTC models are insufficient for comprehensive preclinical drug screening.

Purpose of the Study:

  • To establish and utilize a panel of Japanese biliary tract carcinoma cell lines for drug screening.
  • To evaluate the efficacy of four novel molecular targeting agents against BTC.
  • To identify promising therapeutic targets for biliary tract carcinoma.

Main Methods:

  • Establishment of 13 new cell lines from surgical specimens of Japanese BTC patients.
  • In vitro evaluation of four molecular targeting agents using a panel of 17 BTC cell lines.
  • Assessment of drug activity at submicromolar concentration ranges.

Main Results:

  • The PI3K/mTOR dual inhibitor LY3023414 exhibited potent activity against 13 out of 17 BTC cell lines.
  • Activity was observed even in cell lines resistant to gemcitabine.
  • The BTC cell line panel proved effective for screening novel therapeutic agents.

Conclusions:

  • An in vitro study using a biliary tract carcinoma cell line panel is an efficient method for screening novel therapeutic strategies.
  • PI3K/mTOR dual inhibitors represent a potential therapeutic target for biliary tract carcinoma drug development.
  • Further investigation is warranted to confirm these preliminary findings.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cell Potential and Free Energy02:58

Cell Potential and Free Energy

Thermodynamics of a Redox Reaction
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
46.8K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Wood Panel Products01:18

Wood Panel Products

Wood panel products are essential materials used in construction for applications such as flooring, siding, and roofing, typically available in standard dimensions of 4 feet by 8 feet, with thicknesses varying from one-quarter of an inch to one and one-eighth inches. Among the most common types of wood panels is plywood, which is produced by gluing multiple layers of thin wood veneers under pressure. The grain of the outer veneers runs lengthwise, while the grains of the interior layers run...
417